Pascal Meier

12PUBLICATIONS
79CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsBiologically active moleculesCell development, proliferation and deathMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 06, 2026
Necroptosis in both tumour and stromal compartments determines responsiveness to immunogenic cell death-based immunotherapy.

Winnie Fernando, Jarama Clucas, Alberto Rizzo

|Aug 06, 2025
Harnessing Immunogenic Cell Death to Boost the Impact of Radiation Therapy.

Jonathan Mannion, Pascal Meier

|Jul 15, 2025
Author Correction: Palbociclib and dsRNA sensor co-operate to enhance anti-cancer effects through ER stress and modulation of immune evasion.

Victoria Roulstone, Joan Kyula-Currie, James Wright

|Jul 08, 2025
The PARP inhibitor talazoparib synergizes with reovirus to induce cancer killing and tumour control in vivo in mouse models.

Joan Kyula-Currie, Victoria Roulstone, James Wright

|May 24, 2025
Palbociclib and dsRNA sensor co-operate to enhance anti-cancer effects through ER stress and modulation of immune evasion.

Victoria Roulstone, Joan Kyula-Currie, James Wright

|Aug 01, 2024
Impact of protein and small molecule interactions on kinase conformations.

Valentina Kugler, Selina Schwaighofer, Andreas Feichtner

Pageof 2

Frequent Collaborators

4 joint publications

Jyoti S Choudhary

4 joint publications

Alan Melcher

3 joint publications

James Wright

3 joint publications

Richard Elliott